MedPath

Effects of Probiotics on gut microbiota changes in Children with Attention Deficit/hyperactivity disorder: a double-blind, randomized, placebo-controlled trial

Phase 2
Conditions
Gut dysbiosis and ADHD symptoms in children with ADHD
Gastrointestinal Microbiome
Probiotics
Attention Deficit Disorder with Hyperactivity
Registration Number
TCTR20210211003
Lead Sponsor
Faculty of Medicine, Chiang Mai University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Children fulfilled with DSM-5 criteria for ADHD and healthy children for control group, 2. Participant legally acceptable representative has provided written informed consent to study participation

Exclusion Criteria

1. Had a known neurodevelopmental disorders example for autistic spectrum disorder, global developmental delay, 2. Had a known chronic disorder requiring long term medication including cancers, autoimmune disorders, metabolic disorders or chronic neurological disorders including epilepsy, 3.History of received stimulant, sedative, antipsychotic, beta-blocker, calcium channel-blocker medications within 14 days prior to screening, 4.History of received oral antibiotics within 14 days prior to screening, 5. History of received prebiotics or probiotics within 14 days prior to screening, 6. Participants has a documented allergy, hypersensitivity, or intolerance to any of the ingredients of the intervention, 7 .Selective eating such as vegan, vegetarian

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gut microbiota at allocation time, at 1, 2, 3 month, and at 1 month after intervention Quantitative Polymerase Chain Reaction (qPCR)
Secondary Outcome Measures
NameTimeMethod
Symptoms of ADHD at allocation time, at 1, 2, 3 month, and at 1 month after intervention SNAP-IV, CGI-IS, CGI-I, PedsQL, SDQ, CSHQ
© Copyright 2025. All Rights Reserved by MedPath